Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Population PK-PD Analyses of CD25 Occupancy, CD56(bright) NK Cell Expansion, and Regulatory T Cell Reduction by Daclizumab HYP in Subjects with Multiple Sclerosis.
Neuroimaging in Central Nervous System Lymphoma.
Predictors of first-line treatment persistence in a Portuguese cohort of relapsing-remitting multiple sclerosis.
Combining HLA-DRB1-DQB1 and Mycobacterium Avium Subspecies Paratubercolosis (MAP) antibodies in Sardinian multiple sclerosis patients: associated or independent risk factors?
Periventricular lesions and MS diagnostic criteria in young adults with typical clinically isolated syndromes.
Recovery from Toxic-Induced Demyelination Does Not Require the NG2 Proteoglycan.
The Differential Diagnosis of Multiple Sclerosis Using Convex Combination of Infinite Kernels.
Intracellular ion signaling influences myelin basic protein synthesis in oligodendrocyte precursor cells.
The impact of drugs for multiple sclerosis on sleep.
'Non-criteria' neurologic manifestations of antiphospholipid syndrome: A hidden kingdom to be discovered.
Shared and Distinct Patterns of Oligodendroglial Response in α-Synucleinopathies and Tauopathies.
The Changing Landscape of Childhood Inflammatory Central Nervous System Disorders.
Beta interferon decision is 'disappointing'.
Neurorehabilitation: applied neuroplasticity.
Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy, a time to start and a time to stop.
Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells.
Epilepsy in multiple sclerosis: The role of temporal lobe damage.
Corrigendum to "Evolution of diagnostic criteria for multiple sclerosis" [Pol. J. Neurol. Neurosurg. 49 (5) (2015) 313-321].
US health insurance is an obstacle to disease-modifying treatments in MS.
Abnormal functional connectivity and cortical integrity influence dominant hand motor disability in multiple sclerosis: a multimodal analysis.
Proteolytic regulation of synaptic plasticity in the mouse primary visual cortex: analysis of matrix metalloproteinase 9 deficient mice.
Leuprolide Acetate Inhibits Spinal Cord Inflammatory Response in Experimental Autoimmune Encephalomyelitis by Suppressing NF-x03BA;B Activation.
Reducing costs while enhancing quality of care in MS.
Lithium improves cell viability in psychosine-treated MO3.13 human oligodendrocyte cell line via autophagy activation.
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination.
Pages
« first
‹ previous
…
800
801
802
803
804
805
806
807
808
…
next ›
last »